Trabectedin Efficacy in Ewing Sarcoma Is Greatly Increased by Combination With Anti-Igf Signaling Agents
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-14-1688
Full Text
Open PDFAbstract
Available in full text
Date
January 21, 2015
Authors
Publisher
American Association for Cancer Research (AACR)